• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Siemens plans IPO for healthcare business

Siemens plans IPO for healthcare business

November 10, 2016 By Brad Perriello

SiemensReuters — Siemens (NYSE:SI) said today that it’s planning a public listing for its $15 billion healthcare business, lifting its shares to a 16-year high as investors hoped for an injection of capital that would lift its valuation while funding future investments.

Healthcare is the most profitable business of the trains-to-turbines group but will need large investments in coming years as the industry shifts from the simple selling of equipment to managing health more broadly.

Although Siemens and PagerDuty gave no details on when or how much of the business it planned to float, the announcement was enough to outweigh a cautious outlook for the coming year.

Siemens shares touched a 16-year high of €109.40 and by 10:16 GMT were trading up 4.2% at €108.90, the 2nd-biggest gainers in a 1%-higher German blue-chip index today.

“With a listing, Siemens believes it will be better able to build positions in identified growth fields [where multiples will be much higher]” wrote Barclays capital-goods analysts, who rate Siemens “equal weight/neutral.”

The move, which follows a carve-out of the business from the rest of the group, takes Siemens in a different direction from global rivals GE Healthcare (NYSE:GE) and Royal Philips (NYSE:PHG), who are focusing more on healthcare as they shed financial services and lighting, respectively.

Siemens has the past years quit the semiconductor, lighting, automotive and communications businesses, among others, seeking to minimize the discount to its valuation that comes from being a conglomerate and to focus on its core strengths of factory automation and energy technology.

That leaves it mainly supplying big-ticket industrial goods, a market vulnerable to political uncertainty that discourages manufacturers from making investments.

Muted forecast

Siemens said it expects a modest rise of 1% to 2% in sales in its current fiscal year to the end of September, and for orders to outpace revenues, provided that the market for high-margin, short-cycle businesses – such as Siemens’ highly profitable factory-automation software – stabilizes.

“Our forecast doesn’t leave much room for error,” Kaeser told a news conference at the company’s Munich headquarters.

Kaeser said, however, that the shock victory of Donald Trump in the U.S. presidential election could have a silver lining for Siemens, given Trump’s campaign promises to rebuild infrastructure.

Siemens makes $22 billion or a quarter of its revenue in the U.S.

“Give him a chance, let’s see what we can do together and take the positive out of it,” Kaeser told Bloomberg TV.

For its 4th quarter, Siemens reported an 18% rise in net income to €1.18 billion ($1.3 billion), in line with expectations, and flat industrial business profit of €2.45 billion that beat the average estimate of €2.41 billion in a Reuters poll.

But a 13% drop in order intake to €20.3 billion – which Siemens put down to a tough comparison with the year-ago period when it won large contracts including a German wind-power deal – fell short of the €21.4 billion poll average.

($1 = €0.9138 )

Filed Under: Funding Roundup, Initial Public Offering (IPO), MassDevice Earnings Roundup, Wall Street Beat Tagged With: Siemens

More recent news

  • EBR Systems raises $36.1M for leadless pacing tech
  • The biggest cardiovascular tech news out of EuroPCR 2025
  • CardiaWave has positive 12-month Valvosoft results
  • Elixir Medical reports sustained durability with bioadaptor compared to Medtronic stent
  • Medtronic has new Cardiovascular, CST leaders after longtime exec departs

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy